NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)

Medicine & Life Sciences

1. Portugal 100%
2. Therapeutics 42%
3. Mental Health 42%
4. Systematic Reviews 42%
5. Neoplasms 34%
6. Global Health 33%
7. Population 31%
8. Health Surveys 29%
9. Biomarkers 28%
10. Mortality 26%
11. Cohort Studies 26%
12. Health 25%
13. Genes 23%
14. Pandemics 23%
15. Meta-Analysis 23%
16. Quality of Life 22%
17. Mutation 22%
18. Heart Failure 21%
19. SARS Virus 21%
20. Proteins 20%
21. Infections 20%
22. Child 20%
23. Intensive Care Units 20%
24. Depression 19%
25. Guidelines 19%
26. Pharmaceutical Preparations 19%
27. Mental Disorders 19%
28. Registries 19%
29. Breast Neoplasms 18%
30. Rheumatic Diseases 18%
31. Carotid Body 18%
32. Parkinson Disease 17%
33. Rheumatoid Arthritis 17%
34. Coronavirus 16%
35. Type 2 Diabetes Mellitus 16%
36. Delivery of Health Care 16%
37. Prospective Studies 16%
38. Dementia 16%
39. Cross-Sectional Studies 16%
40. Critical Illness 15%
41. Asthma 15%
42. Exercise 15%
43. Diet 15%
44. Confidence Intervals 15%
45. Glucose 14%
46. Odds Ratio 14%
47. Coronary Artery Disease 14%
48. Phenotype 14%
49. Zebrafish 14%
50. Kidney 13%
51. Food 13%
52. Rheumatology 13%
53. Insulin Resistance 13%
54. Survival 13%
55. Thyroid Neoplasms 13%
56. Liver 13%
57. Observational Studies 13%
58. Inflammation 13%
59. Insulin 12%
60. Blood Vessels 12%
61. Lung 12%
62. Caregivers 12%
63. Obesity 12%
64. C-Reactive Protein 12%
65. Safety 12%
66. Obstructive Sleep Apnea 12%
67. Randomized Controlled Trials 11%
68. Hypertension 11%
69. Retrospective Studies 11%
70. Antirheumatic Agents 11%
71. Gold 11%
72. Serum 11%
73. Pediatrics 11%
74. Economics 11%
75. Elderly 11%
76. Primary Health Care 11%
77. Epidemiology 11%
78. Fibromyalgia 11%
79. In Vitro Techniques 11%
80. DNA 11%
81. Comorbidity 11%
82. Ankylosing Spondylitis 11%
83. Income 10%
84. Pregnancy 10%
85. Multicenter Studies 10%
86. Osteoarthritis 10%
87. Sleep 10%
88. Incidence 10%
89. Antiphospholipid Syndrome 10%
90. Bone and Bones 10%
91. Antibodies 10%
92. Pain 10%
93. Education 10%
94. Costs and Cost Analysis 10%
95. Clinical Trials 10%
96. Consensus 10%
97. Arteries 10%
98. Logistic Models 10%
99. Optical Coherence Tomography 10%
100. Eye 10%